Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran
{{output}}
Objectives: To assess the comparative budget and health impact of lower-dose dabigatran versus reduced doses of apixaban and rivaroxaban in atrial fibrillation (AF) patients eligible for a lower-/reduced-dose due to individual patient characteristics in the Ne... ...
